Products
-
Rick Doblin on the FDA's MDMA Decision and the Future of Psychedelic Therapy
CourseTimely insights from Rick Doblin on the FDA's decision on MDMA and its impact on psychedelic research and therapy in 2025.
Free
-
Balancing Safety & Access Webinar Series: Healing Trauma with Psychedelics
CourseDiscover how to balance safety with access in trauma healing. Explore pharmacology, ancestral trauma, and the role of psychedelics in therapeutic practices. Join diverse voices discussing innovative healing methods and their implications.
$10
-
Balancing Safety & Access Webinar Series: Psychedelics for End of Life & Existential distress
CourseJoin us for a crucial discussion on providing safe and accessible psychedelic therapy to individuals facing end-of-life or existential distress due to mental health challenges. Hear from experts on the ethical, legal, and social implications.
$10
-
Balancing Safety & Access Webinar Series: The Impact of Canadian Psychedelics Law on Indigenous Ways of Healing
Course$10
-
Balancing Safety & Access Webinar Series: Training for Psychedelics-Assisted Care Providers
CourseEnhance your therapeutic practice with our comprehensive training for psychedelic-assisted care providers. Led by experts, this course offers critical skills, legal guidance, and ethical frameworks essential for integrating psychedelics into therapy
$10
-
Balancing Safety & Access Webinar Series: Cost Coverage for Psychedelic Assisted-Care
CourseUnderstand British Columbia's approach to drug cost coverage. This course offers insights into the PharmaCare drug review process, detailing how drugs are assessed for safety, effectiveness, and value before being recommended for public plan cover.
$10